Fabentech raises €20.0M Growth round
7 October 2024· Lyon, France· health, biotech, materials, b2b, b2g, deep_hardware
The funding will accelerate R&D, bioproduction, commercialization, and expansion efforts, and strengthen the development and deployment of broad-spectrum therapeutics to combat the highest-priority biological threats to public health.
Investors
LeadEuropean Investment Bank
About Fabentech
Stage
Series A
Headquarters
Lyon, France
Founded
2009
Team Size
21–50
Sectors
healthbiotechmaterialsb2bb2gdeep_hardware